Bone And Joint Health Supplements Market Size, Share & Trends Analysis Report By Product (Vitamins, Mineral, Collagen, Omega-3, Glucosamine), By Formulation, By Consumer Group, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Bone And Joint Health Supplements Market Size, Share & Trends Analysis Report By Product (Vitamins, Mineral, Collagen, Omega-3, Glucosamine), By Formulation, By Consumer Group, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030


Bone And Joint Health Supplements Market Growth & Trends

The global bone and joint health supplements market size is expected to reach USD 6.33 billion by 2030, expanding at a CAGR of 3.77% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of orthopedic disorders among the geriatric and adult population is one of the major factors driving the market. According to the CDC, around 58.5 million people are diagnosed with arthritis and it is more common in women as compared to men. Also, the increasing burden of arthritis is anticipated to drive the industry during the forecast period. As per the CDC, around 78.4 million adults aged 18 years and above are anticipated to be diagnosed with arthritis. Moreover, the rising geriatric population across the globe is fueling industry growth as the prevalence of orthopedic disorders increases with age. Around 49.6% of people aged above 65 years are diagnosed with arthritis.

Furthermore, the rising health consciousness, increasing consumer interest in active living, and rising disposable income are among the key factors driving the industry. In addition, increasing awareness regarding micronutrient deficiencies, increasing access to supplements, availability of multiple products, and the increasing number of distribution channels are supporting the growth.

Moreover, the increasing focus of key companies on various strategies to meet consumer demand is impelling market growth. For instance, in March 2022, Bioiberica entered into a partnership with ByHealth to develop a product for joint health brand “Highflex” in the China market. Furthermore, the manufacturers are developing new supplements in various formulations to attract the consumer base, thereby positively impacting the industry's growth. For instance, in February 2022, Gadot Biochemical Industries launched ‘Cal2Mag’, a new mineral blend combining calcium and magnesium, to specifically target bone health.

Bone And Joint Health Supplements Market Report Highlights
  • The market is anticipated to grow owing to the increasing consumption of supplements for bone health, increasing access to supplements, and rising prevalence of micronutrient deficiencies among adults
  • The vitamin product segment dominated the market in 2023 due to the increasing prevalence of vitamin D deficiency in children and adults. This, in turn, is raising the demand for vitamin supplements to support bone and joint health
  • The capsules formulation segment held the largest share in 2023 owing to its high preference due to the ease of consumption
  • Based on consumer group, the geriatric population segment dominated the market in 2023 owing to the increasing prevalence of arthritis and osteoporosis among the geriatric population and the rising incidence of bone fractures due to osteoporosis
  • By sales channel, in 2023, the bricks and mortar segment held the largest share owing to the presence of a large number of providers, lucrative discounts, and high
  • North America dominated the market in 2023 due to the increasing number of people suffering from joint disorders and rising awareness regarding healthy and active lifestyle
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Formulation Segment
1.2.3. Consumer Group Segment
1.2.4. Sales Channel Segment
1.3. Information Analysis
1.4. Market Formulation & Data Visualization
1.5. Data Validation & Publishing
1.6. Research Assumptions
1.7. Information Procurement
1.7.1. Primary Research
1.8. Information or Data Analysis
1.9. Market Formulation & Validation
1.10. Market Model
1.11. Global Market: CAGR Calculation
1.12. Objective
1.12.1. Objective 1
1.12.2. Objective2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rapidly Growing Geriatric Population And Increasing Prevalence Of Orthopedic Disorders.
3.2.1.2. Rising Awareness Regarding Micronutrient Deficiencies
3.2.1.3. Rising Focus Of Market Players On Developing Bone And Joint Supplements
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost Of The Supplements
3.2.2.2. Lack Of Knowledge Regarding Bone And Joint Health Supplements In Low And Middle Income Countries
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Bone and Joint Health Supplements Market: Product Movement Analysis
4.2. Vitamins
4.2.1. Vitamins Market, 2018 - 2030 (USD Million)
4.3. Mineral
4.3.1. Mineral Market, 2018 - 2030 (USD Million)
4.4. Collagen
4.4.1. Collagen Market, 2018 - 2030 (USD Million)
4.5. Omega-3
4.5.1. Omega-3 Market, 2018 - 2030 (USD Million)
4.6. Glucosamine
4.6.1. Glucosamine Market, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Formulation Business Analysis
5.1. Bone and Joint Health Supplements Market: Formulation Movement Analysis
5.2. Capsule
5.2.1. Capsule Market, 2018 - 2030 (USD Million)
5.3. Tablet
5.3.1. Tablet Market, 2018 - 2030 (USD Million)
5.4. Powder
5.4.1. Powder Market, 2018 - 2030 (USD Million)
5.5. Softgels
5.5.1. Softgels Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Consumer Group Business Analysis
6.1. Bone and Joint Health Supplements Market: Consumer Group Movement Analysis
6.2. Infants
6.2.1. Infants Market, 2018 - 2030 (USD Million)
6.3. Children
6.3.1. Children Market, 2018 - 2030 (USD Million)
6.4. Adults
6.4.1. Adults Market, 2018 - 2030 (USD Million)
6.5. Pregnant Women
6.5.1. Pregnant Women Market, 2018 - 2030 (USD Million)
6.6. Geriatric Population
6.6.1. Geriatric Population Market, 2018 - 2030 (USD Million)
Chapter 7. Sales Channel Business Analysis
7.1. Bone and Joint Health Supplements Market: Sales Channel Movement Analysis
7.2. Bricks and Mortar
7.2.1. Bricks and Mortar Market, 2018 - 2030 (USD Million)
7.2.2. Direct Selling
7.2.2.1. Direct Selling Market, 2018 - 2030 (USD Million)
7.2.3. Chemists/Pharmacies
7.2.3.1. Chemists/Pharmacies Market, 2018 - 2030 (USD Million)
7.2.4. Health Food Shop
7.2.4.1. Health Food Shop Market, 2018 - 2030 (USD Million)
7.2.5. Hypermarket
7.2.5.1. Hypermarket Market, 2018 - 2030 (USD Million)
7.2.6. Supermarkets
7.2.6.1. Supermarkets Market, 2018 - 2030 (USD Million)
7.3. E-Commerce
7.3.1. E-Commerce Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Bone and Joint Health Supplements Market Share, By Region, 2023 & 2030
8.2. North America
8.2.1. North America Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Target Disease Prevalence
8.2.2.3. Competitive Scenario
8.2.2.4. Regulatory Framework
8.2.2.5. U.S. Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. Canada Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Target Disease Prevalence
8.3.2.3. Competitive Scenario
8.3.2.4. Regulatory Framework
8.3.2.5. UK Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. Germany Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. France Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. Italy Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Spain Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Denmark Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Sweden Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Norway Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Competitive Scenario
8.4.2.4. Regulatory Framework
8.4.2.5. Japan Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. China Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. India Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. Australia Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.4.6. Thailand
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Thailand Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.4.7. South Korea
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. South Korea Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Competitive Scenario
8.5.2.4. Regulatory Framework
8.5.2.5. Brazil Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Mexico Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Argentina Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Competitive Scenario
8.6.2.4. Regulatory Framework
8.6.2.5. South Africa Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. Saudi Arabia Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. UAE Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. Kuwait Bone and Joint Health Supplements Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Company Profiles/Listing
9.4.1. Herbalife International of America, Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. GNC Holdings, LLC
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Nature's Bounty
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. BYHEALTH Co., Ltd.
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Amway
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. BASF SE
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Bayer AG
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Vitalife Ltd
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Glanbia plc
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. NOW Foods
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings